Double-blind randomized phase 3 study comparing esaxerenone (CS-3150) and eplerenone in patients with essential hypertension (ESAX-HTN Study)
S Ito, H Itoh, H Rakugi, Y Okuda, M Yoshimura… - …, 2020 - Am Heart Assoc
Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
S Ito, H Itoh, H Rakugi, Y Okuda… - … (Dallas, Tex.: 1979 …, 2020 - pubmed.ncbi.nlm.nih.gov
Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study).
S Ito, H Itoh, H Rakugi, Y Okuda… - … (Dallas, Tex.: 1979), 2019 - europepmc.org
Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
Clinical Trial
Hypertension, 2020 - Am Heart Assoc
Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
S Ito, H Itoh, H Rakugi, Y Okuda… - … (Dallas, Tex.: 1979), 2020 - keio.elsevierpure.com
抄録 Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
S Ito, H Itoh, H Rakugi, Y Okuda, M Yoshimura… - Hypertension, 2020 - cir.nii.ac.jp
抄録< jats: p> Mineralocorticoid receptors (MRs) are implicated in the pathology of
hypertension. MR blockers are recommended for the treatment of salt-sensitive or resistant …
hypertension. MR blockers are recommended for the treatment of salt-sensitive or resistant …
Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
S Ito, H Itoh, H Rakugi, Y Okuda… - … (Dallas, Tex.: 1979), 2020 - keio.elsevierpure.com
Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …
blockers are recommended for the treatment of salt-sensitive or resistant hypertension …